Not Yet RecruitingNot Applicable

Dynamic Multilevel Processes of Recovery in Therapeutic Communities in Mexico (DICO Model)

Mexico60 participantsStarted 2026-05-15

Plain-language summary

This study aims to develop and empirically evaluate the Dinámica Integral Conductual Comunitaria (DICO) model, a multilevel framework that conceptualizes recovery from substance use disorders as a dynamic process emerging from the interaction between individual behavioral variables, social contingencies, and community-level factors within therapeutic communities in Mexico. A prospective longitudinal design with intensive repeated measures will be implemented over 8 to 12 weeks. Data will be collected using ecological momentary assessment (EMA), psychometric instruments, behavioral records, and semi-structured interviews. The study seeks to model recovery trajectories as nonlinear dynamic systems, identifying critical transitions, instability patterns, and contextual moderators associated with treatment adherence and relapse risk.

Who can participate

Age range

18 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18 years or older * Currently enrolled in a residential therapeutic community for substance use treatment * Minimum stay of at least 7 days prior to baseline assessment * Ability to understand and provide informed consent * Expected availability for participation during the 8-12 week follow-up period Exclusion Criteria: * Acute psychotic symptoms or severe psychiatric decompensation that interferes with participation * Severe cognitive impairment limiting comprehension of study procedures * Current medical instability requiring immediate external intervention * Refusal to participate in any component of the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Treatment Adherence - Length of Stay

Timeframe: From admission to discharge (up to 12 weeks)

Disengagement - Total Score on Brief Disengagement Scale

Timeframe: Every 48 hours from Week 1 through Week 12 (up to 12 weeks)

Craving Intensity - Single-Item Scale

Timeframe: Every 48 hours from Week 1 through Week 12 (up to 12 weeks)

Contextual Rumination - Total Score on the Brief Contextual Rumination Scale (BCRS-10)

Timeframe: Every 48 hours from Week 1 through Week 12 (up to 12 weeks)

Temporal Variability of Craving

Timeframe: Derived from repeated measurements collected every 48 hours from Week 1 through Week 12

Autocorrelation of Craving (Lag-1)

Timeframe: Derived from repeated measurements collected every 48 hours from Week 1 through Week 12

Trial details

NCT IDNCT07588516

SponsorUnder The Tree Therapeutic Community

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09-26

Contact for this trial

Lauro Gutiérrez Castro, Mtro.

+523314696107 saraqael_sefer@hotmail.com

View on ClinicalTrials.gov More Substance Use Disorder (SUD) trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Treatment Adherence - Length of Stay

Timeframe: From admission to discharge (up to 12 weeks)

Disengagement - Total Score on Brief Disengagement Scale

Timeframe: Every 48 hours from Week 1 through Week 12 (up to 12 weeks)

Craving Intensity - Single-Item Scale

Timeframe: Every 48 hours from Week 1 through Week 12 (up to 12 weeks)

Contextual Rumination - Total Score on the Brief Contextual Rumination Scale (BCRS-10)

Timeframe: Every 48 hours from Week 1 through Week 12 (up to 12 weeks)

Temporal Variability of Craving

Timeframe: Derived from repeated measurements collected every 48 hours from Week 1 through Week 12

Autocorrelation of Craving (Lag-1)

Timeframe: Derived from repeated measurements collected every 48 hours from Week 1 through Week 12